ATE204480T1 - Monoklonaler antikörper, welcher spezifisch an vaskularisiertes tumorendothelium bindet und verwendungen davon - Google Patents

Monoklonaler antikörper, welcher spezifisch an vaskularisiertes tumorendothelium bindet und verwendungen davon

Info

Publication number
ATE204480T1
ATE204480T1 AT94901335T AT94901335T ATE204480T1 AT E204480 T1 ATE204480 T1 AT E204480T1 AT 94901335 T AT94901335 T AT 94901335T AT 94901335 T AT94901335 T AT 94901335T AT E204480 T1 ATE204480 T1 AT E204480T1
Authority
AT
Austria
Prior art keywords
dothelium
glycoprotein
monoclonal antibody
binds specifically
vascularized tumor
Prior art date
Application number
AT94901335T
Other languages
English (en)
Inventor
Pilar Garin-Chesa
Wolfgang J Rettig
Lloyd J Old
Original Assignee
Ludwig Inst Cancer Res
Sloan Kettering Inst Cancer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ludwig Inst Cancer Res, Sloan Kettering Inst Cancer filed Critical Ludwig Inst Cancer Res
Application granted granted Critical
Publication of ATE204480T1 publication Critical patent/ATE204480T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/855—Proteins from animals other than mammals or birds
    • Y10S530/857—Fish; fish eggs; shell fish; crustacea

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT94901335T 1992-11-13 1993-11-09 Monoklonaler antikörper, welcher spezifisch an vaskularisiertes tumorendothelium bindet und verwendungen davon ATE204480T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/976,405 US5342757A (en) 1992-11-13 1992-11-13 Monoclonal antibodies which specifically binds to endosialin, a 165 Kd glycoprotein found on tumor vascular endothelium, and uses thereof
PCT/US1993/010773 WO1994011023A1 (en) 1992-11-13 1993-11-09 Monoclonal antibody which specifically binds to tumor vascular endothelium and uses thereof

Publications (1)

Publication Number Publication Date
ATE204480T1 true ATE204480T1 (de) 2001-09-15

Family

ID=25524065

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94901335T ATE204480T1 (de) 1992-11-13 1993-11-09 Monoklonaler antikörper, welcher spezifisch an vaskularisiertes tumorendothelium bindet und verwendungen davon

Country Status (12)

Country Link
US (2) US5342757A (de)
EP (1) EP0673255B1 (de)
JP (1) JP3541296B2 (de)
AT (1) ATE204480T1 (de)
AU (1) AU671884B2 (de)
CA (1) CA2149120C (de)
DE (1) DE69330643T2 (de)
DK (1) DK0673255T3 (de)
ES (1) ES2161751T3 (de)
GR (1) GR3036906T3 (de)
PT (1) PT673255E (de)
WO (1) WO1994011023A1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965132A (en) * 1992-03-05 1999-10-12 Board Of Regents, The University Of Texas System Methods and compositions for targeting the vasculature of solid tumors
US5776427A (en) * 1992-03-05 1998-07-07 Board Of Regents, The University Of Texas System Methods for targeting the vasculature of solid tumors
US6004555A (en) * 1992-03-05 1999-12-21 Board Of Regents, The University Of Texas System Methods for the specific coagulation of vasculature
US6093399A (en) * 1992-03-05 2000-07-25 Board Of Regents, The University Of Texas System Methods and compositions for the specific coagulation of vasculature
EP1306095A3 (de) * 1992-03-05 2003-06-25 Board Of Regents, The University Of Texas System Methoden und Zusammensetzungen zur Zielrichtung der Gefässe von festen Tumoren
US6749853B1 (en) * 1992-03-05 2004-06-15 Board Of Regents, The University Of Texas System Combined methods and compositions for coagulation and tumor treatment
US6036955A (en) * 1992-03-05 2000-03-14 The Scripps Research Institute Kits and methods for the specific coagulation of vasculature
US5877289A (en) * 1992-03-05 1999-03-02 The Scripps Research Institute Tissue factor compositions and ligands for the specific coagulation of vasculature
EP0746613B1 (de) * 1994-03-08 2006-05-24 Memorial Sloan-Kettering Cancer Center Rekombinante humanisierte antikörper gegen fb5
US5536641A (en) * 1994-05-17 1996-07-16 Memorial Sloane Kittering Cancer Center Monoclonal antibody specific for vascular endothelial cell antigen endoglyx-1 and uses thereof for detection of, and isolation of, vascular endothelial cells
ES2241313T3 (es) 1998-03-31 2005-10-16 Bristol-Myers Squibb Pharma Company Compuestos farmaceuticos para la formacion de imagenes de trastornos angiogenicos.
US6524553B2 (en) 1998-03-31 2003-02-25 Bristol-Myers Squibb Pharma Company Quinolone vitronectin receptor antagonist pharmaceuticals
US6548663B1 (en) 1998-03-31 2003-04-15 Bristol-Myers Squibb Pharma Company Benzodiazepine vitronectin receptor antagonist pharmaceuticals
US6537520B1 (en) * 1998-03-31 2003-03-25 Bristol-Myers Squibb Pharma Company Pharmaceuticals for the imaging of angiogenic disorders
US6511649B1 (en) * 1998-12-18 2003-01-28 Thomas D. Harris Vitronectin receptor antagonist pharmaceuticals
EP1140864A2 (de) 1998-12-18 2001-10-10 Du Pont Pharmaceuticals Company Pharmazeutische zusammensetzungen, vitronectinrezeptor antagonisten enthaltend
NZ511677A (en) 1998-12-18 2003-10-31 Du Pont Pharm Co Vitronectin receptor antagonist pharmaceuticals
US6794518B1 (en) * 1998-12-18 2004-09-21 Bristol-Myers Squibb Pharma Company Vitronectin receptor antagonist pharmaceuticals
US6569402B1 (en) 1998-12-18 2003-05-27 Bristol-Myers Squibb Pharma Company Vitronectin receptor antagonist pharmaceuticals
WO2002010217A2 (en) * 2000-08-02 2002-02-07 The Johns Hopkins University Endothelial cell expression patterns
US7951061B2 (en) 2001-07-25 2011-05-31 Allan Foreman Devices for targeted delivery of thermotherapy, and methods related thereto
US7074175B2 (en) 2001-07-25 2006-07-11 Erik Schroeder Handy Thermotherapy via targeted delivery of nanoscale magnetic particles
US7731648B2 (en) 2001-07-25 2010-06-08 Aduro Biotech Magnetic nanoscale particle compositions, and therapeutic methods related thereto
US6997863B2 (en) 2001-07-25 2006-02-14 Triton Biosystems, Inc. Thermotherapy via targeted delivery of nanoscale magnetic particles
EP1534331B1 (de) * 2002-06-21 2014-10-29 Johns Hopkins University School of Medicine Membran-assoziierte tumorendothel-marker
CN1832965B (zh) * 2003-03-04 2011-03-02 麒麟麦酒株式会社 内皮细胞特异性抗体及其用途
ATE476449T1 (de) * 2004-12-03 2010-08-15 Morphotek Inc Verwendung von endosialinbindenden proteinen zum isolieren endosialinpositiver zellen
AU2006241235B2 (en) * 2005-04-22 2012-04-05 Eisai, Inc. Antibodies with immune effector activity and that internalize in endosialin-positive cells
RS55447B1 (sr) 2007-04-05 2017-04-28 Morphotek Inc Metode za inhibiranje vezivanja endosijalina za ligande
US20100260769A1 (en) * 2009-04-09 2010-10-14 Morphotek, Inc. Endosialin binding molecules
SE535982C2 (sv) * 2009-12-15 2013-03-19 Theravac Pharmaceuticals Ab Ett nytt vaccin som angriper tumörkärl som ett effektivt redskap i tumörterapi
US20130305396A1 (en) 2010-09-29 2013-11-14 Luigi Grasso Engineered human endosialin-expressing rodents
EP2831114B1 (de) 2012-03-30 2019-05-08 Eisai R&D Management Co., Ltd. Diagnostische tem-1-antikörper
WO2022203314A2 (ko) * 2021-03-24 2022-09-29 재단법인 아산사회복지재단 악성말초신경초종의 감별진단을 위한 조성물

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0746613B1 (de) * 1994-03-08 2006-05-24 Memorial Sloan-Kettering Cancer Center Rekombinante humanisierte antikörper gegen fb5

Also Published As

Publication number Publication date
US5342757A (en) 1994-08-30
AU671884B2 (en) 1996-09-12
DK0673255T3 (da) 2001-12-10
EP0673255A4 (de) 1996-08-21
EP0673255B1 (de) 2001-08-22
GR3036906T3 (en) 2002-01-31
CA2149120C (en) 2005-09-27
WO1994011023A1 (en) 1994-05-26
DE69330643T2 (de) 2002-07-04
JPH08505764A (ja) 1996-06-25
EP0673255A1 (de) 1995-09-27
PT673255E (pt) 2002-02-28
ES2161751T3 (es) 2001-12-16
AU5596594A (en) 1994-06-08
CA2149120A1 (en) 1994-05-26
JP3541296B2 (ja) 2004-07-07
DE69330643D1 (de) 2001-09-27
US5437865A (en) 1995-08-01

Similar Documents

Publication Publication Date Title
DE69330643D1 (de) Monoklonaler antikörper, welcher spezifisch an vaskularisiertes tumorendothelium bindet und verwendungen davon
Capra et al. Light chain sequences of human IgM cold agglutinins
DE69807679D1 (de) Zusammensetzungen aus konjugaten des stabilen, aktiven, menschlichen ob proteins mit der fc kette von immunoglobulinen und damit zusammenhängende verfahren
EP0728215A4 (de) METHODE ZUR BINDUNG VON MATERIAL AN DAS -g(b)-AMYLOID-PEPTID
UA29494C2 (uk) Гуманізовані антитіла, способи їх продукування, спосіб лікування хвороби крона, спосіб лікування розсіяного склерозу, фармацевтична композиція
KR960704576A (ko) CD40에 대한 항체(Antibodies to CD40)
WO1998057994A3 (en) Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
KR930703008A (ko) 복합된 특이성 융합 단백질
ATE512224T1 (de) Rekonstituierter menschlicher anti-hm.1 antikörper
ATE208820T1 (de) Humanisierte antikoerper
RU94045826A (ru) Моноклональные антитела против рецептора интерферона, с нейтрализующим действием против интерферона типа i
ATE177758T1 (de) Synthetische peptide, antikörper dagegen und ihre verwendung
DE69333673D1 (de) Epitope von Stress Proteinen
ES8801729A1 (es) Un ensayo inmunometrio para proteina p21ras humana
GB9009106D0 (en) Processes and intermediates for synthetic antibody derivatives
FI873410A0 (fi) Kahden uuden hybridooman tuottamia apolipoproteiini-B-spesifisiä monoklonaalisia vasta-aineita
EP0725081A4 (de) MONOKLONALER ANTIKÖRPER GEGEN MxA DES MENSCHLICHEN Mx PROTEINS
CA2126182A1 (en) Humanized antibodies reactive with gpiib/iiia
GR3033708T3 (en) Fusion proteins with monoclonal antibody, Linker and beta Glucuronidase for prodrug activation; preparation and use thereof.
EP0822828A4 (de) Isolierte proteine mit 55-75 kda, die an das prion-protein anbinden
CA2137280A1 (fr) Clonage du gene codant pour la proteine gp28.5 de toxoplasma gondii; fragments peptidiques de cette proteine et leurs applications
NO972522L (no) Monoklonale antistoffer med immunoundertrykkende aktivitet
DK0513565T3 (da) Monoklonale antistoffer mod plasmin-antiplasmin-komplekset, fremgangsmåde til deres fremstilling og deres anvendelse
DE69010897D1 (de) Verwendung von monoklonalen Antikörpern gegen B2-Mikroglobulin.
EP0749981A4 (de) Monoklonaler antikörper

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification